Novel GPR139 agonist evaluated in schizophrenia mouse model
Nov. 28, 2023
GPR139 is an orphan G protein-coupled receptor expressed in neurons of the mediobasal hypothalamus that has been proposed as a target for disorders such as Parkinson’s disease, alcohol addiction or schizophrenia, among others.